First Trust Nasdaq Pharmaceuticals ETF
FTXH
NASDAQ
| Weiss Ratings | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B- | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Valuation | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $27.57 | |||
| Company Info | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | First Trust | |||
| Manager/Tenure (Years) | Jon C. Erickson (8), Daniel J. Lindquist (8), David G. McGarel (8), 4 others | |||
| Website | http://www.ftportfolios.com/ | |||
| Phone Number | 800-621-1675 | |||
| Fund Information | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | First Trust Nasdaq Pharmaceuticals ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Sep 20, 2016 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.71% | |||
| Dividend | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.58% | |||
| Asset Allocation | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.07% | |||
| Stock | 99.93% | |||
| U.S. Stock | 99.93% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 4.55% | |||
| 30-Day Total Return | 6.03% | |||
| 60-Day Total Return | 8.24% | |||
| 90-Day Total Return | 7.82% | |||
| Year to Date Total Return | 2.99% | |||
| 1-Year Total Return | -3.86% | |||
| 2-Year Total Return | 6.04% | |||
| 3-Year Total Return | 9.06% | |||
| 5-Year Total Return | 20.24% | |||
| Price | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $27.47 | |||
| 1-Month Low Price | $25.77 | |||
| 1-Month High Price | $27.57 | |||
| 52-Week Low Price | $23.57 | |||
| 52-Week Low Price (Date) | Apr 10, 2025 | |||
| 52-Week High Price | $29.66 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| NAV | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $25.81 | |||
| 1-Month High NAV | $27.57 | |||
| 52-Week Low NAV | $23.64 | |||
| 52-Week Low NAV (Date) | Apr 10, 2025 | |||
| 52-Week High NAV | $29.67 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| Beta / Standard Deviation | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.60 | |||
| Standard Deviation | 13.82 | |||
| Balance Sheet | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 14.21M | |||
| Operating Ratios | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.60% | |||
| Turnover Ratio | -- | |||
| Performance | FTXH - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 10.30% | |||
| Last Bear Market Total Return | -0.31% | |||